Osteoarthritis :: Prexige 200mg and 400mg tablets to be withdrawn in New Zealand
Consents allowing the supply of 200mg and 400mg tablets of the COX-2 anti-inflammatory medicine Prexige have been revoked in New Zealand by the Medicines and Medical Devices Safety Authority, Medsafe.